Trials / Completed
CompletedNCT00417820
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
A Multicenter, Double-Blind, Placebo Controlled Exploratory Study to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Administration of BCT194 in Healthy Volunteers and Multiple Administrations in Patients With Psoriasis.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the local tolerability of a single topical administration of BCT194 in healthy volunteers and, potentially, to evaluate the safety, tolerability, and efficacy of a multiple topical administrations in patients with psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BCT194 |
Timeline
- Start date
- 2006-11-01
- Completion
- 2007-11-01
- First posted
- 2007-01-04
- Last updated
- 2007-11-29
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00417820. Inclusion in this directory is not an endorsement.